TFFP Stock Summary and Trading Ideas (TFF Pharmaceuticals | NASDAQ:TFFP)

TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.

TFF Pharmaceuticals trades on the NASDAQ stock market under the symbol TFFP.

As of April 18, 2024, TFFP stock price declined to $3.13 with 26,469 million shares trading.

TFFP has a beta of 1.16, meaning it tends to be more sensitive to market movements. TFFP has a correlation of 0.02 to the broad based SPY ETF.

TFFP has a market cap of $7.90 million. This is considered a Sub-Micro Cap stock.

Last quarter TFF Pharmaceuticals reported $114,328 in Revenue and -$2.01 earnings per share. This beat revenue expectation by $14,328 and exceeded earnings estimates by $.11.

In the last 3 years, TFFP stock traded as high as $307.00 and as low as $3.00.

The top ETF exchange traded funds that TFFP belongs to (by Net Assets): VTI, VXF.

TFFP has underperformed the market in the last year with a price return of -81.6% while the SPY ETF gained +22.3%. TFFP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -41.2% and -37.3%, respectively, while the SPY returned +6.1% and -3.8%, respectively.

TFFP support price is $2.89 and resistance is $3.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFFP stock will trade within this expected range on the day.